Niacin

Niacin

SCHEMBL987479

O=C([O-])c1cccnc1.[Li+]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Niacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
GAA P10253 2/20 0.63
APP P05067 1/20 0.63
HCAR3 P49019 1/20 0.63
HCAR2 Q8TDS4 1/20 0.63
F7 P08709 1/20 0.61
F3 P13726 1/20 0.61
SARM1 Q6SZW1 1/20 0.61
SIRT2 Q8IXJ6 1/20 0.61
SIRT6 Q8N6T7 1/20 0.61
SIRT1 Q96EB6 1/20 0.61
SIRT3 Q9NTG7 1/20 0.61
SIRT5 Q9NXA8 1/20 0.61
SIRT4 Q9Y6E7 1/20 0.61
HDAC1 Q13547 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
PLOD2 O00469 2/20 0.53
LMNA P02545 3/20 0.52
THRB P10828 1/20 0.52
HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacin SCHEMBL30468338 1.00 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL1943861 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL587526 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL6012008 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL25269786 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL23780930 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL3498987 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL10357700 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL308681 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL517582 0.96 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12506143-B2 Electrode plate, electrochemical apparatus, and electronic apparatus NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-12-23 US claimed
US-20230238519-A1 ELECTRODE PLATE, ELECTROCHEMICAL APPARATUS, AND ELECTRONIC APPARATUS NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2023-07-27 US claimed
EP-0272903-B1 PROCESS FOR PRODUCING A POLYARYLENE SULFIDE Tosoh Corporation (JP) 1993-07-21 EP claimed
US-4794163-A HIGH MOLECULAR WEIGHT, HEAT RESISTANCE TOSOH CORPORATION (JP) 1988-12-27 US claimed
EP-0272903-A2 Process for producing a polyarylene sulfide Tosoh Corporation (JP) 1988-06-29 EP claimed
JP-1249754-A None JP disclosed
JP-1249754-A None JP disclosed
US-12506143-B2 Electrode plate, electrochemical apparatus, and electronic apparatus NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-12-23 US disclosed
EP-4439911-A1 ELECTROCHEMICAL DEVICE AND CONTROL METHOD THEREFOR, ELECTRONIC DEVICE, AND STORAGE MEDIUM Ningde Amperex Technology Limited (CN) 2024-10-02 EP disclosed
US-20240313277-A1 ELECTROCHEMICAL APPARATUS AND CONTROL METHOD THEREFOR, ELECTRONIC APPARATUS, AND STORAGE MEDIUM NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-09-19 US disclosed
US-20240304784-A1 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-09-12 US disclosed
EP-4428938-A1 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS Ningde Amperex Technology Limited (CN) 2024-09-11 EP disclosed
US-20110009665-A1 Acetic acid production by way of carbonylation with enhanced reaction and flashing CELANESE INTERNATIONAL CORPORATION 2011-01-13 US disclosed
WO-2011005304-A2 ACETIC ACID PRODUCTION BY WAY OF CARBONYLATION WITH ENHANCED REACTION AND FLASHING CELANESE INTERNATIONAL CORPORATION (US) 2011-01-13 WO disclosed
EP-0272903-B1 PROCESS FOR PRODUCING A POLYARYLENE SULFIDE Tosoh Corporation (JP) 1993-07-21 EP disclosed
US-4908374-A Nicotinic acid lithium salt ODESSKY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA, ODESSA, USSR 1990-03-13 US disclosed
JP-H01249754-A LITHIUM NICOTINATE SALT SEMIHYDRATE AND PHARMACEUTICAL PREPARATION BASED THEREON FOR PREVENTION AND TREATMENT OF ALCOHOLIC INTOXICATION ODESKY MEDIZIN INST IM NI PIROGOVA 1989-10-05 JP disclosed
JP-H01249754-A LITHIUM NICOTINATE SALT SEMIHYDRATE AND PHARMACEUTICAL PREPARATION BASED THEREON FOR PREVENTION AND TREATMENT OF ALCOHOLIC INTOXICATION ODESKY MEDIZIN INST IM NI PIROGOVA 1989-10-05 JP disclosed
US-4794163-A HIGH MOLECULAR WEIGHT, HEAT RESISTANCE TOSOH CORPORATION (JP) 1988-12-27 US disclosed
EP-0272903-A2 Process for producing a polyarylene sulfide Tosoh Corporation (JP) 1988-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009665-A1 Acetic acid production by way of carbonylation with enhanced reaction and flashing DNMT1, SP1, ME1 ALDH1A1 253/4885GAA 4409/4885APP 4735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.